title: Screening for mutations in the cystic fibrosis transmembrane regulator gene in an infertility clinic.
abstract: In 2001, the American College of Obstetricians and Gynecologists recommended screening for cystic fibrosis mutations in all Caucasian couples who were planning pregnancy or seeking prenatal care. Since 2001 we have offered cystic fibrosis screening to all Caucasian infertility patients. Only 2% of our patients have elected to have mutation screening for cystic fibrosis.
authors.affiliation: Sanford School of Medicine, Sioux Falls, South Dakota 57105, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Slostad
authors.forename: Quinn P
authors.initials: QP
authors.lastname: Stein
authors.forename: Jason D
authors.initials: JD
authors.lastname: Flanagan
authors.forename: Keith A
authors.initials: KA
authors.lastname: Hansen
mesh_terms: D000554:Ambulatory Care Facilities; D003550:Cystic Fibrosis / Q000209:etiology / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D005191:Family Characteristics; D005260:Female; D006580:Genetic Carrier Screening; D005820:Genetic Testing / Q000191:economics; D006801:Humans; D007246:Infertility / Q000235:genetics; D008297:Male; D009154:Mutation; D012307:Risk Factors
chemical_list: D019005:Cystic Fibrosis Transmembrane Conductance Regulator